Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Garnero

Showing results (131-140 of 146) with videos related to

Pageof 15
Sort By:
Annals of the Rheumatic Diseases|August 5, 2005
Urinary CTX-II levels are associated with radiographic subtypes of osteoarthritis in hip, knee, hand, and facet joints in subject with familial osteoarthritis at multiple sites: the GARP studyI Meulenbelt, M Kloppenburg, H M Kroon, et al.
Osteoarthritis and Cartilage|October 24, 2007
Biochemical markers of type II collagen breakdown and synthesis are positioned at specific sites in human osteoarthritic knee cartilageA-C Bay-Jensen, T L Andersen, N Charni-Ben Tabassi, et al.
Annals of the Rheumatic Diseases|November 15, 2005
Urinary CTX-II and glucosyl-galactosyl-pyridinoline are associated with the presence and severity of radiographic knee osteoarthritis in menK M Jordan, H E Syddall, P Garnero, et al.
Annals of the Rheumatic Diseases|July 16, 2008
Tight control and intensified COBRA combination treatment in early rheumatoid arthritis: 90% remission in a pilot trialL H D van Tuyl, W F Lems, A E Voskuyl, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|May 8, 2003
The type I collagen fragments ICTP and CTX reveal distinct enzymatic pathways of bone collagen degradationP Garnero, M Ferreras, M A Karsdal, et al.
Osteoarthritis and Cartilage|June 14, 2001
Recommendations for the registration of drugs used in the treatment of osteoarthritis: an update on biochemical markersE Vignon, P Garnero, P Delmas, et al.
Osteoarthritis and Cartilage|November 13, 2007
Relationships between biochemical markers of bone and cartilage degradation with radiological progression in patients with knee osteoarthritis receiving risedronate: the Knee Osteoarthritis Structural Arthritis randomized clinical trialP Garnero, W S Aronstein, S B Cohen, et al.
Osteoarthritis and Cartilage|June 24, 2008
Serum protein signatures detect early radiographic osteoarthritisS M Ling, D D Patel, P Garnero, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|December 25, 2010
Markers of bone turnover for the prediction of fracture risk and monitoring of osteoporosis treatment: a need for international reference standardsS Vasikaran, R Eastell, O Bruyère, et al.
Arthritis and Rheumatism|June 1, 2006
The ratio of circulating osteoprotegerin to RANKL in early rheumatoid arthritis predicts later joint destructionP P Geusens, R B M Landewé, P Garnero, et al.
Pageof 15

Showing results (131-140 of 146) with videos related to

Sort By:
Pageof 15
Annals of the Rheumatic Diseases|August 5, 2005
Urinary CTX-II levels are associated with radiographic subtypes of osteoarthritis in hip, knee, hand, and facet joints in subject with familial osteoarthritis at multiple sites: the GARP studyI Meulenbelt, M Kloppenburg, H M Kroon, et al.
Osteoarthritis and Cartilage|October 24, 2007
Biochemical markers of type II collagen breakdown and synthesis are positioned at specific sites in human osteoarthritic knee cartilageA-C Bay-Jensen, T L Andersen, N Charni-Ben Tabassi, et al.
Annals of the Rheumatic Diseases|November 15, 2005
Urinary CTX-II and glucosyl-galactosyl-pyridinoline are associated with the presence and severity of radiographic knee osteoarthritis in menK M Jordan, H E Syddall, P Garnero, et al.
Annals of the Rheumatic Diseases|July 16, 2008
Tight control and intensified COBRA combination treatment in early rheumatoid arthritis: 90% remission in a pilot trialL H D van Tuyl, W F Lems, A E Voskuyl, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|May 8, 2003
The type I collagen fragments ICTP and CTX reveal distinct enzymatic pathways of bone collagen degradationP Garnero, M Ferreras, M A Karsdal, et al.
Osteoarthritis and Cartilage|June 14, 2001
Recommendations for the registration of drugs used in the treatment of osteoarthritis: an update on biochemical markersE Vignon, P Garnero, P Delmas, et al.
Osteoarthritis and Cartilage|November 13, 2007
Relationships between biochemical markers of bone and cartilage degradation with radiological progression in patients with knee osteoarthritis receiving risedronate: the Knee Osteoarthritis Structural Arthritis randomized clinical trialP Garnero, W S Aronstein, S B Cohen, et al.
Osteoarthritis and Cartilage|June 24, 2008
Serum protein signatures detect early radiographic osteoarthritisS M Ling, D D Patel, P Garnero, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|December 25, 2010
Markers of bone turnover for the prediction of fracture risk and monitoring of osteoporosis treatment: a need for international reference standardsS Vasikaran, R Eastell, O Bruyère, et al.
Arthritis and Rheumatism|June 1, 2006
The ratio of circulating osteoprotegerin to RANKL in early rheumatoid arthritis predicts later joint destructionP P Geusens, R B M Landewé, P Garnero, et al.
Pageof 15